Vitamin B12 Replacement Regimen
For patients with malabsorption (including pernicious anemia, post-bariatric surgery, or gastrointestinal disorders), use intramuscular hydroxocobalamin 1 mg, with the specific regimen determined by presence or absence of neurological involvement. 1
Algorithm for Treatment Selection
Step 1: Assess for Neurological Involvement
Look specifically for:
- Unexplained sensory symptoms (paresthesias, numbness)
- Motor symptoms (weakness, gait disturbance)
- Cognitive changes
- Subacute combined degeneration of the spinal cord
If neurological symptoms present:
- Hydroxocobalamin 1 mg IM on alternate days until no further improvement
- Then maintenance: 1 mg IM every 2 months lifelong 1
- Seek urgent specialist advice from neurologist and haematologist 1
If no neurological involvement:
- Hydroxocobalamin 1 mg IM three times weekly for 2 weeks
- Then maintenance: 1 mg IM every 2-3 months lifelong 1
Step 2: Route Selection Based on Absorption Capacity
For malabsorption conditions (use parenteral route):
- Pernicious anemia
- Post-bariatric surgery (RYGB, BPD/DS)
- Inflammatory bowel disease (particularly with ileal involvement)
- Gastrointestinal malabsorption syndromes
- Atrophic gastritis
The FDA label explicitly states: "Oral absorption is considered too undependable to rely on in patients with pernicious anemia or other conditions resulting in malabsorption of vitamin B12" 2, 3
For dietary deficiency or food-cobalamin malabsorption without severe malabsorption:
- Oral cyanocobalamin 1000 μg (1 mg) daily is effective 4, 5, 6
- This dose achieves normalization through passive diffusion (approximately 1% absorption of large doses) 2
- High-dose oral therapy (1000-2000 μg daily) has demonstrated efficacy in multiple studies 4, 5, 7
Important Clinical Nuances
Oral vs. Parenteral Debate: While recent research suggests high-dose oral therapy (≥1000 μg daily) can be effective even in some malabsorption conditions 4, 5, 6, 8, the guidelines and FDA labeling prioritize parenteral therapy for malabsorption. The 2020 British Obesity and Metabolic Surgery Society guidelines specifically recommend routine IM supplementation following malabsorptive procedures 1. This conservative approach is justified given the risk of irreversible neurological damage from inadequate treatment.
Critical Pitfall - Folate Administration: Never give folic acid before treating B12 deficiency, as it may mask underlying B12 deficiency and precipitate subacute combined degeneration of the spinal cord 1. Always check and treat B12 deficiency first.
Maintenance Dosing Variability: The guidelines specify maintenance every 2-3 months 1, though clinical experience suggests up to 50% of patients may require more frequent dosing (ranging from every 2-4 weeks) to remain symptom-free 9. Titration should be based on clinical symptoms, not biomarker levels 9.
Oral Dosing for Non-Malabsorption: When oral therapy is appropriate, use 1 mg tablets rather than 50 μg tablets—they are more cost-effective (£0.33 vs £0.43) and likely more effective due to higher passive absorption 10. The minimum effective dose for food-cobalamin malabsorption is 125-250 μg daily 5, 11, but 1000 μg daily is preferred for reliability.
Special Population - Metformin Users: Patients on long-term metformin have 7-11% absolute risk of B12 deficiency 12 and may require monitoring and supplementation.